Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)
Clinical trial NCT03888534 · WITHDRAWN
Trial details
- NCT number
- NCT03888534
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-31
- Primary completion
- 2022-08-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.